MedPath

Investigating the effect of magnesum sulfate in reducing the pain of kidney stones

Phase 2
Recruiting
Conditions
Acute renal colic.
Calculus of kidney
N20.0
Registration Number
IRCT20221219056870N1
Lead Sponsor
Dezfoul University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
184
Inclusion Criteria

Patients older than 16 years
Patients with flank or hypogastric pain
Patients who have ultrasound based on kidney stones.

Exclusion Criteria

Known hypersensitivity to ketorolac and morphine or magnesium sulfate
Pregnancy and breastfeeding
Any history of opium addiction
Breathing rate less than 12 per minute
Systolic blood pressure less than 100 mm Hg
Unwillingness to participate in the study
Inability to understand the concept of VAS
Heart or kidney failure
Use of painkillers 4 hours before admission

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain reduction of 3 points or more on the VAS scale after drug injection is considered positive. Timepoint: 20, 40 and 60 minutes. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath